Mass drug dosing aims to stamp out malaria in peru
NCT ID NCT05690841
First seen Nov 01, 2025 · Last updated Apr 24, 2026 · Updated 27 times
Summary
This study tests whether giving anti-malarial drugs to everyone in a village can reduce and eventually eliminate vivax malaria. Over 7,500 people in rural Peru will be split into two groups: one receiving standard care (bed nets, screening) and the other also receiving mass drug administration. The goal is to see if this approach lowers new infections over 3 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asociación Civil Selva Amazónica
RECRUITINGIquitos, Peru
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.